Novartis created the Novartis Research Institute for Tropical Diseases in Singapore. The institute is unique because it is a not-for-profit organization that focuses on the discovery of new drugs for the treatment of neglected diseases, such as dengue fever and tuberculosis. Not only is this good business, it is also:

A. mandated by Supreme Court rulings
B. socially responsible
C. not ethically motivated
D. demonstrating a lack of concern for diversity
E. using environmental marketing

B. Socially responsible.

Explanation:

Tuberculosis and Dengue fever are endemic to the tropical regions of West Africa and the south Americas. Tuberculosis is of public health importance and affects millions of people in these regions yearly. It is caused by a bacteria called mycobacterium tuberculosis and is highly contagious. It mostly attacks the airways and lungs but can also affect other organs like the liver in people with weak or absent immunity such as in conditions like HIV and cancer. It is spread through air droplets when people with the infection cough, sneeze or spit. Tuberculosis can be cured and prevented and this is possible through the various researches done by companies like Novartis.

Dengue fever is a viral infection caused by mosquitoes in the tropical regions. It's symptoms include high fever, joint pains, bleeding and shock. There's no known cure for it.

Other neglected diseases include; hookworm infection, ascariasis, schistosomiasis, leprosy and trypanosomiasis also known as African sleeping sickness and caused by trypanosoma brucei.

Novartis research centers for tropical diseases offer social responsibility in looking into these neglected but fatal diseases and trying to find ways in which we can better manage and prevent them. Manufacturing affordable and readily available medications and providing them in these impoverished regions says a lot about the social responsibility and ethical standards of this company and therefore putting their name out there as one of today's global heavyweights in pharmaceuticals as well as charitable organizations.

you will have $2593.74 in 10 years if you set aside $1,000 at 10%

you will have $9321.91 in 20 years if you set aside $2000 at 8%

you will have $1469.32 in 5 years if you set aside $1000 at 8%

you will have $1296.87 in 10 years if you set aside $500 at 10%

you will have $239.66 in 15 years if you set aside $100 at 6%

you will have $4660.96 in 20 years if you set aside $1000 at 8%